title: Performance improvement CME: managing schizophrenia.
abstract: Schizophrenia is a highly disabling disorder characterized by positive and negative symptoms and poor functioning in almost every area of life. Multiple antipsychotics have demonstrated varying levels of efficacy in reducing symptoms in schizophrenia, but adverse effects are common, adherence to medication is low, and relapse rates are high. Psychosocial interventions used in conjunction with antipsychotic pharmacotherapy may help improve treatment outcomes. This Performance Improvement CME activity focuses on individualizing treatment for schizophrenia, assessing treatment adherence, minimizing medication-induced adverse events, and preventing relapse, for children, adolescents, and adults with schizophrenia.
authors.affiliation: Department of Psychiatry, The Zucker Hillside Hospital, Glen Oaks, and the Department of Psychiatry and Behavioral Sciences, Albert Einstein College of Medicine of Yeshiva University, Bronx, NY, USA.
authors.forename: John M
authors.initials: JM
authors.lastname: Kane
authors.forename: Christoph U
authors.initials: CU
authors.lastname: Correll
mesh_terms: D000293:Adolescent; D000328:Adult; D002648:Child; D003131:Combined Modality Therapy; D019468:Disease Management; D006801:Humans; D011613:Psychotherapy; D012559:Schizophrenia / Q000188:drug therapy / Q000628:therapy; D016896:Treatment Outcome; D055815:Young Adult